… based on the following inclusion criteria: original research, cohort study, reported change
in management after somatostatin receptor imaging, and number of patients 10 or more. …

… Besides in vitro studies, clinical trials compared the efficacy of PAS with first-generation
SRLs in acromegalic patients at various stage of disease management (eg de-novo patients, …

… However, only for those patients who have somatostatin receptor-negative tumors is chemotherapy
effective. 34 The effect on patient management is fourfold: SRI may detect resectable …

… Tumor localization for accurate staging and therapeutic management justifies the use of
new imaging techniques such as endoscopie ultrasonography (EUS) (7,8) and somatostatin …

Somatostatin receptor scintigraphy (SRS) is being increasingly used both for localization
and, in some cases, diagnosis of various diseases. There are no prospectivestudies of its …

… of tumor growth, as well as the improvement of patient’s survival and quality of life. The
management of patients with NETs may require a multidisciplinary approach and different kinds …

… of somatostatin-receptor scintigraphy (SRS) in the management of patients with GEP tumors.
… Among our patients, transient regression of receptor-positive liver metastases was evident …

… CgA in patients with carcinoid … somatostatin receptor subtype 2 and 5 expression [14].
The aim of our study was to investigate the impact of SRS versus plasma CgA assay in patients …

… SRS altered management in 47% overall and in 22%- 60% of patients in the five different …
management. SRS was equally useful in patients with or without metastatic liver disease. …

… P1 indicates purely somatostatin receptor-positive lesions … FDG-positive/somatostatin
receptor-negative disease. In the … of patients, the authors used only three groups: P1 (11 patients…